Is NICXF or HDV a better dividend investment in 2026?

NICXF currently yields 666.67% with a 5% 5-year dividend growth rate. HDV yields 2.92% with 4.8% growth. The better choice depends on your goal: NICXF offers higher current income.

What is the dividend yield difference between NICXF and HDV?

NICXF has a forward dividend yield of 666.67% ($2.00/share annually). HDV yields 2.92% ($3.96/share annually). The yield gap is 663.75 percentage points.

Home › Compare › NICXF vs HDV

NICXF vs HDV: Dividend Comparison 2026

NICXF yields 666.67% · HDV yields 2.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NICXF wins by $608115.63M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NICXF

● Live price

666.67%

Share price

$0.30

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$608115.66M

Annual income

$469,561,018,816.25

Full NICXF calculator →

HDV

iShares Core High Dividend ETF

● Live price

2.92%

Share price

$135.72

Annual div

$3.96

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.3K

Annual income

$351.71

Full HDV calculator →

Portfolio growth — NICXF vs HDV

📍 NICXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NICXF	HDV
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NICXF + HDV cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NICXF pays

HDV pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NICXF

Annual income on $10K today (after 15% tax)

$56,666.67/yr

After 10yr DRIP, annual income (after tax)

$399,126,865,993.81/yr

HDV

Annual income on $10K today (after 15% tax)

$247.92/yr

After 10yr DRIP, annual income (after tax)

$298.95/yr

At 15% tax rate, NICXF beats the other by $399,126,865,694.86/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NICXF + HDV for your $10,000?

NICXF: 50%HDV: 50%

100% HDV50/50100% NICXF

Portfolio after 10yr

$304057.84M

Annual income

$234,780,509,583.98/yr

Blended yield

77.22%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NICXF buys

HDV buys

No recent congressional trades found for NICXF or HDV in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNICXFHDV

Forward yield	666.67% ✓	2.92%
Annual dividend / share	$2.00	$3.96 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$608115.66M ✓	$24.3K
Annual income after 10y	$469,561,018,816.25 ✓	$351.71
Total dividends collected	$596792.85M ✓	$3.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: NICXF vs HDV ($10,000, DRIP)

Year	NICXF Portfolio	NICXF Income/yr	HDV Portfolio	HDV Income/yr	Gap
1← crossover	$77,367	$66,666.67	$11,002	$291.67	+$66.4K → NICXF
2	$564,818	$482,035.31	$12,082	$299.61	+$552.7K → NICXF
3	$3,893,246	$3,288,890.67	$13,247	$307.23	+$3.88M → NICXF
4	$25,352,760	$21,186,987.16	$14,503	$314.52	+$25.34M → NICXF
5	$156,070,781	$128,943,327.59	$15,854	$321.50	+$156.05M → NICXF
6	$908,837,800	$741,842,064.29	$17,308	$328.15	+$908.82M → NICXF
7	$5,009,769,782	$4,037,313,336.56	$18,871	$334.49	+$5009.75M → NICXF
8	$26,159,339,258	$20,798,885,591.56	$20,551	$340.53	+$26159.32M → NICXF
9	$129,490,317,125	$101,499,824,118.87	$22,357	$346.27	+$129490.29M → NICXF
10	$608,115,658,140	$469,561,018,816.25	$24,296	$351.71	+$608115.63M → NICXF

NICXF vs HDV: Complete Analysis 2026

NICXF — Stock

Nicox S.A. operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating prostaglandin analog for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in phase 3 clinical trial. The company is also developing NCX 4251, a proprietary formulation of fluticasone for acute exacerbations of blepharitis that is in a Phase 2b clinical trial for the treatment of acute exacerbations of blepharitis; and NCX 1728.It offers VYZULTA, a latanoprostene bunod ophthalmic solution to treat patients with open-angle glaucoma or ocular hypertension; and ZERVIATE, a cetirizine ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis. The company was founded in 1996 and is headquartered in Valbonne, France.

Full NICXF Calculator →

HDV — ETF

The iShares Core High Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full HDV Calculator →

📬

Get this NICXF vs HDV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NICXF vs SCHD NICXF vs JEPI NICXF vs O NICXF vs KO NICXF vs MAIN NICXF vs VYM NICXF vs DVY NICXF vs SPHD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.